Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Histiocytoma, Malignant Fibrous × Surgical Procedures, Operative × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 16 Breast Neoplasms 10 Sarcoma 9 Neoplasms 8 Glioblastoma 8 Stomach Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 7 Esophageal Neoplasms 7 Rectal Neoplasms 6 Brain Neoplasms 6 Urinary Bladder Neoplasms 5 Carcinoma, Hepatocellular 5 Recurrence 4 Prostatic Neoplasms 4 Oropharyngeal Neoplasms 4 Neoplasm Metastasis 4 Lung Neoplasms 4 Hypopharyngeal Neoplasms 4 Glioma 4 Colonic Neoplasms 4 Thyroid Neoplasms 3 Pancreatic Neoplasms 3 Mouth Neoplasms 3 Melanoma 3 Laryngeal Neoplasms 3 Head and Neck Neoplasms 3 Colorectal Neoplasms 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Skin Neoplasms 2

Interventions

pembrolizumab 4 Specimen Handling 3 Doxorubicin 3 Radiotherapy 2 Radiation 2 Nivolumab 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 CTLA-4 Antigen 2 Biopsy 2 tremelimumab 1 talimogene laherparepvec 1 regorafenib 1 pazopanib 1 olaratumab 1 futibatinib 1 fludarabine 1 eribulin 1 durvalumab 1 cabozantinib 1 avelumab 1 aldesleukin 1 X-Rays 1 Trabectedin 1 Standard of Care 1 Quality of Life 1 Immune Checkpoint Inhibitors 1 Ifosfamide 1 Histamine H2 Antagonists 1 Famotidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡